These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25584718)

  • 1. Clinical challenges of thyroid eye disease in HIV-positive patients on highly active antiretroviral therapy.
    Edmunds MR; Mellington F; Ford RL; Torlinska B; Manavi K; Boelaert K
    J Clin Endocrinol Metab; 2015 Mar; 100(3):779-87. PubMed ID: 25584718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
    Edmunds MR; Boelaert K
    Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of Graves' disease in patients with thyroid eye disease].
    Sviridenko NY; Sheremeta MS; Belovalova IM; Melnichenko GA
    Vestn Oftalmol; 2021; 137(6):128-135. PubMed ID: 34965078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmic complications in juvenile Graves' Disease - clinic and therapeutic approaches.
    Krassas GE
    Pediatr Endocrinol Rev; 2003 Dec; 1 Suppl 2():223-9; discussion 229. PubMed ID: 16444162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
    Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
    Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.
    Gaitan Cepeda LA; Ceballos Salobreña A; López Ortega K; Arzate Mora N; Jiménez Soriano Y
    Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E85-93. PubMed ID: 18223535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients.
    Jubault V; Penfornis A; Schillo F; Hoen B; Izembart M; Timsit J; Kazatchkine MD; Gilquin J; Viard JP
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4254-7. PubMed ID: 11095463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors of Thyroid Eye Disease.
    Lee MH; Chin YH; Ng CH; Nistala KRY; Ow ZGW; Sundar G; Yang SP; Khoo CM
    Endocr Pract; 2021 Mar; 27(3):245-253. PubMed ID: 33655885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management.
    Yu CY; Ford RL; Wester ST; Shriver EM
    Indian J Ophthalmol; 2022 Jul; 70(7):2335-2345. PubMed ID: 35791115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
    Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
    Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Other Autoimmune Diseases With Thyroid Eye Disease.
    Kelada M; Avari P; Farag S; Akishar R; Jain R; Aziz A; Feeney C; Bravis V; Meeran K; Lee V
    Front Endocrinol (Lausanne); 2021; 12():644200. PubMed ID: 33746907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of pediatric thyroid eye disease: the Asian experience.
    Sim B; Chng CL; Audrey C; Seah LL
    Orbit; 2022 Feb; 41(1):69-78. PubMed ID: 33059514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral versus unilateral thyroid eye disease.
    Kashkouli MB; Kaghazkanani R; Heidari I; Ketabi N; Jam S; Azarnia S; Pakdel F
    Indian J Ophthalmol; 2011; 59(5):363-6. PubMed ID: 21836341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of thyroid eye disease in Graves' disease: A meta-analysis and systematic review.
    Chin YH; Ng CH; Lee MH; Koh JWH; Kiew J; Yang SP; Sundar G; Khoo CM
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):363-374. PubMed ID: 32691849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution in HIV+ subjects on lopinavir/ritonavir-based HAART according to the severity of pre-therapy CD4+.
    Marchetti G; Merlini E; Sinigaglia E; Iannotti N; Bai F; Savoldi A; Tincati C; Carpani G; Bini T; Arminio Monforte A
    Curr HIV Res; 2012 Oct; 10(7):597-605. PubMed ID: 22716104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "Quiet TED"-A Special Subgroup of Thyroid Eye Disease.
    Iñiguez-Ariza NM; Sharma A; Garrity JA; Stan MN
    Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):551-555. PubMed ID: 33782324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA.
    Twizerimana AP; Mwatha J; Musabyimana JP; Kayigi E; Harelimana Jde D; Karanja SM; Mutesa L
    East Afr Med J; 2014 Aug; 91(8):261-6. PubMed ID: 26862650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity of thyroid eye disease and type-2 diabetes mellitus: Is there a correlation?
    Ramamurthy LB; Rangarajan V; Srirao N; Malini B; Bansal R; Yuvarajan K
    Indian J Ophthalmol; 2020 Jun; 68(6):1127-1131. PubMed ID: 32461446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Vitamin D Deficiency Is an Independent Risk Factor for Thyroid Eye Disease.
    Heisel CJ; Riddering AL; Andrews CA; Kahana A
    Ophthalmic Plast Reconstr Surg; 2020; 36(1):17-20. PubMed ID: 31568022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.